Who owns the FORZINITY (ELAMIPRETIDE HCI) INJECTION trademark?

The FORZINITY (ELAMIPRETIDE HCI) INJECTION trademark is owned by STEALTH BIOTHERAPEUTICS INC..

What class is the FORZINITY (ELAMIPRETIDE HCI) INJECTION trademark registered in?

The FORZINITY (ELAMIPRETIDE HCI) INJECTION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for FORZINITY (ELAMIPRETIDE HCI) INJECTION?

The USPTO serial number for FORZINITY (ELAMIPRETIDE HCI) INJECTION is 99087371.

What is the registration number for FORZINITY (ELAMIPRETIDE HCI) INJECTION?

FORZINITY (ELAMIPRETIDE HCI) INJECTION is registered under USPTO registration number 0.

FOR

USPTO Trademark Record

PENDING

FORZINITY (ELAMIPRETIDE HCI) INJECTION

SN 99087371·Reg 0·Filed Mar 17, 2025

Owner STEALTH BIOTHERAPEUTICS INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

FORZINITY (ELAMIPRETIDE HCI) INJECTION (Serial No. 99087371), Registration No. 0, is a pending US trademark filed on Mar 17, 2025 by STEALTH BIOTHERAPEUTICS INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Office Action response: December 24, 202657 days remaining

Mark Intelligence

FORZINITY (ELAMIPRETIDE HCI) INJECTION (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 17, 2025

SERIAL

99087371

REG#

Owner

Applicant

STEALTH BIOTHERAPEUTICS INC.

Entity

Corporation

State

Address

123 Highland Ave, Suite 201, Needham, MA, 02494

Country

Attorney

NameTricia L. Schulz

Law firm

Tricia L. Schulz Foley & Lardner LLP

Docket

091151-1670

Address

Suite 5000, 150 E. Gilman Street, Madison, WI 53703, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateMar 17, 2025

Serial Number99087371

Registration No.0

Status DateSep 24, 2026

Published for OppositionDec 23, 2025

Mark TypeDesign with words

Attorney Docket091151-1670

Status DescriptionLive and pending, statement of use non-final action mailed

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jan 21, 2026

First use in commerce: Jan 21, 2026

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

27 events

SU - NON-FINAL ACTION - WRITTEN

Sep 24, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Sep 24, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 24, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 07, 2026

SOU TEAS EXTENSION RECEIVED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 15, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jul 15, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

May 01, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 01, 2026

USE AMENDMENT FILED

POST PUBLICATION AMENDMENT – NOT ENTERED

Mar 30, 2026

POST PUBLICATION AMENDMENT – NOT ENTERED

ASSIGNED TO PETITION STAFF

Mar 27, 2026

ASSIGNED TO PETITION STAFF

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 17, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

TEAS POST PUBLICATION AMENDMENT RECEIVED

Jan 28, 2026

TEAS POST PUBLICATION AMENDMENT RECEIVED

PUBLISHED FOR OPPOSITION

Dec 23, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 23, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 17, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 20, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 14, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 14, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 14, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 19, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 19, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 19, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 15, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 05, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 05, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Mar 17, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 17, 2025

APPLICATION FILING RECEIPT MAILED

FORZINITY (ELAMIPRETIDE HCI) INJECTION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by STEALTH BIOTHERAPEUTICS INC.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Tricia L. Schulz

Industries

USPTO Deadlines

Compare

Resources

Company